Key facts
- This page summarizes Brian Newman's Form 4 filing for CVS HEALTH Corp (CVS).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 01 Jun 2026, 17:02.
Brian Newman - 31 May 2026 Form 4 Insider Report for CVS HEALTH Corp (CVS)
- Reporting relationship
- EVP, Chief Financial Officer
- Issuer ticker
- CVS
- Reported as of
- 31 May 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 01 Jun 2026, 17:02:36 UTC
- Prior SEC filing
- 13 May 2026
- Next SEC filing
- 02 Jul 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Brian Newman
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Brian Newman filed Form 4 for CVS HEALTH Corp (CVS) on 01 Jun 2026.
Change
- Previous filing in this sequence was filed on 13 May 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001788049
Primary reporting owner
Newman Brian
- Relationship
- EVP, Chief Financial Officer
- Address
- ONE CVS DRIVE, WOONSOCKET
- Signature
- /s/ Brian Newman
- Signature date
- 01 Jun 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CVS
transaction
Common Stock
Tax liability
- Transaction value
- Shares
- -2,478
- Change %
- -45%
- Price
- $90.98*
- Shares after
- 3,008
- Date
- 31 May 2026
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Surrender of shares in payment of withholding taxes due upon the vesting and settlement of a restricted stock unit award.